Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL OCULAR IMPLANTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL OCULAR IMPLANTS MARKET
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 MULTIVARIATE MODELLING
2.2.5 TOP TO BOTTOM ANALYSIS
2.2.6 STANDARDS OF MEASUREMENT
2.2.7 VENDOR SHARE ANALYSIS
2.2.8 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.9 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL OCULAR IMPLANTS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
5.3 VALUE CHAIN ANALYSIS
5.4 STRENGHT OF PRODUCT PORTFOLIO
5.5 BUSINESS STRATEGY EXCELLENCE
5.6 CASE STUDIES
5.7 TECHNOLOGICAL TRENDS
5.8 PRICING ANALYSIS
5.9 SUPPLY CHAIN ANALYSIS
6 INDUSTRY INSIGHTS
7 REGULATORY FRAMEWORK
8 GLOBAL OCULAR IMPLANTS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 INTRAOCULAR LENSES (IOLS)
8.2.1 BY FUNCTIONALITY
8.2.1.1. MONOFOCAL IOLS
8.2.1.2. MULTIFOCAL IOLS
8.2.1.3. TORIC IOLS
8.2.1.4. ACCOMMODATIVE IOLS
8.2.1.5. OTHERS
8.2.2 BY MATERIAL
8.2.2.1. PMMA IOLS
8.2.2.2. FOLDABLE ACRYLIC IOLS (HYDROPHOBIC & HYDROPHILIC)
8.2.2.3. SILICONE IOLS
8.2.3 BY DESIGN
8.2.3.1. ANTERIOR CHAMBER IOLS
8.2.3.2. POSTERIOR CHAMBER IOLS
8.2.3.3. PHAKIC IOLS
8.3 CORNEAL IMPLANTS
8.3.1 BY TYPE
8.3.1.1. SYNTHETIC CORNEAL IMPLANTS
8.3.1.2. BIOLOGICAL CORNEAL IMPLANTS
8.3.2 BY INDICATION
8.3.2.1. KERATOCONUS
8.3.2.2. CORNEAL SCARRING
8.3.2.3. FUCHS' DYSTROPHY
8.3.2.4. OTHER
8.4 ORBITAL IMPLANTS
8.4.1 POROUS ORBITAL IMPLANTS
8.4.2 NON-POROUS ORBITAL IMPLANTS
8.5 GLAUCOMA IMPLANTS
8.5.1 BY TYPE
8.5.1.1. AQUEOUS SHUNT DEVICES
8.5.1.2. MICROINVASIVE GLAUCOMA SURGERY (MIGS) IMPLANTS
8.5.1.3. OTHERS
8.5.2 BY MATERIAL
8.5.2.1. SILICONE
8.5.2.2. POLYPROPYLENE
8.6 OCULAR PROSTHETICS (ARTIFICIAL EYE IMPLANTS)
8.6.1 BY TYPE
8.6.1.1. STOCK PROSTHETIC EYES
8.6.1.2. CUSTOM PROSTHETIC EYES
8.6.2 BY MATERIAL
8.6.2.1. PMMA
8.6.2.2. GLASS-BASED PROSTHETICS
8.7 OTHERS
9 GLOBAL OCULAR IMPLANTS MARKET, BY MATERIAL
9.1 OVERVIEW
9.2 POLYMETHYL METHACRYLATE (PMMA)
9.3 HYDROPHOBIC ACRYLIC
9.4 HYDROPHILIC ACRYLIC
9.5 SILICONE
9.6 HYDROGEL
9.7 COLLAGEN-BASED BIOMATERIALS
9.8 POLYETHYLENE
9.9 OTEHRS
10 GLOBAL OCULAR IMPLANTS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 GLAUCOMA SURGERY
10.3 OCUPLASTY, DRUG DELIVERY
10.4 AGE-RELATED MACULAR DEGENERATION
10.5 AESTHETIC PURPOSE
10.6 OTHERS
11 GLOBAL OCULAR IMPLANTS MARKET, BY END-USER
11.1 OVERVIEW
11.2 EYE SPECIALTY CLINICS
11.3 EYE INSTITUTES
11.4 AMBULATORY SURGICAL CENTERS
11.5 SPECIALTY CLINICS
11.6 HOSPITALS
11.7 OTHERS
12 GLOBAL OCULAR IMPLANTS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.3.1 ONLINE
12.3.2 OFFLINE
12.4 OTHER
13 GLOBAL OCULAR IMPLANTS MARKET, BY REGION
GLOBAL OCULAR IMPLANTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
13.2 EUROPE
13.2.1 GERMANY
13.2.2 U.K.
13.2.3 ITALY
13.2.4 FRANCE
13.2.5 SPAIN
13.2.6 RUSSIA
13.2.7 SWITZERLAND
13.2.8 TURKEY
13.2.9 BELGIUM
13.2.10 NETHERLANDS
13.2.11 DENMARK
13.2.12 SWEDEN
13.2.13 POLAND
13.2.14 NORWAY
13.2.15 FINLAND
13.2.16 REST OF EUROPE
13.3 ASIA PACIFIC
13.3.1 JAPAN
13.3.2 CHINA
13.3.3 SOUTH KOREA
13.3.4 INDIA
13.3.5 SINGAPORE
13.3.6 THAILAND
13.3.7 INDONESIA
13.3.8 MALAYSIA
13.3.9 PHILIPPINES
13.3.10 AUSTRALIA
13.3.11 NEW ZEALAND
13.3.12 VIETNAM
13.3.13 TAIWAN
13.3.14 REST OF ASIA-PACIFIC
13.4 SOUTH AMERICA
13.4.1 BRAZIL
13.4.2 ARGENTINA
13.4.3 REST OF SOUTH AMERICA
13.5 MIDDLE EAST AND AFRICA
13.5.1 SOUTH AFRICA
13.5.2 EGYPT
13.5.3 BAHRAIN
13.5.4 UNITED ARAB EMIRATES
13.5.5 KUWAIT
13.5.6 OMAN
13.5.7 QATAR
13.5.8 SAUDI ARABIA
13.5.9 REST OF MEA
13.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
14 GLOBAL OCULAR IMPLANTS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
14.5 MERGERS & ACQUISITIONS
14.6 NEW PRODUCT DEVELOPMENT & APPROVALS
14.7 EXPANSIONS
14.8 REGULATORY CHANGES
14.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
15 GLOBAL OCULAR IMPLANTS MARKET, SWOT ANALYSIS
16 GLOBAL OCULAR IMPLANTS MARKET, COMPANY PROFILE
16.1 ALCON, INC.
16.1.1 COMPANY OVERVIEW
16.1.2 REVENUE ANALYSIS
16.1.3 GEOGRAPHIC PRESENCE
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 JOHNSON & JOHNSON VISION
16.2.1 COMPANY OVERVIEW
16.2.2 REVENUE ANALYSIS
16.2.3 GEOGRAPHIC PRESENCE
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 BAUSCH + LOMB
16.3.1 COMPANY OVERVIEW
16.3.2 REVENUE ANALYSIS
16.3.3 GEOGRAPHIC PRESENCE
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 CARL ZEISS AG
16.4.1 COMPANY OVERVIEW
16.4.2 REVENUE ANALYSIS
16.4.3 GEOGRAPHIC PRESENCE
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 STAAR SURGICAL
16.5.1 COMPANY OVERVIEW
16.5.2 REVENUE ANALYSIS
16.5.3 GEOGRAPHIC PRESENCE
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 MORCHER GMBH
16.6.1 COMPANY OVERVIEW
16.6.2 REVENUE ANALYSIS
16.6.3 GEOGRAPHIC PRESENCE
16.6.4 PRODUCT PORTFOLIO
16.6.5 RECENT DEVELOPMENTS
16.7 GLAUKOS CORPORATION
16.7.1 COMPANY OVERVIEW
16.7.2 REVENUE ANALYSIS
16.7.3 GEOGRAPHIC PRESENCE
16.7.4 PRODUCT PORTFOLIO
16.7.5 RECENT DEVELOPMENTS
16.8 SCIENCE CORPORATION
16.8.1 COMPANY OVERVIEW
16.8.2 REVENUE ANALYSIS
16.8.3 GEOGRAPHIC PRESENCE
16.8.4 PRODUCT PORTFOLIO
16.8.5 RECENT DEVELOPMENTS
16.9 CORNEAGEN
16.9.1 COMPANY OVERVIEW
16.9.2 REVENUE ANALYSIS
16.9.3 GEOGRAPHIC PRESENCE
16.9.4 PRODUCT PORTFOLIO
16.9.5 RECENT DEVELOPMENTS
16.1 PRESBIA
16.10.1 COMPANY OVERVIEW
16.10.2 REVENUE ANALYSIS
16.10.3 GEOGRAPHIC PRESENCE
16.10.4 PRODUCT PORTFOLIO
16.10.5 RECENT DEVELOPMENTS
16.11 ALLERGAN (ABBVIE)
16.11.1 COMPANY OVERVIEW
16.11.2 REVENUE ANALYSIS
16.11.3 GEOGRAPHIC PRESENCE
16.11.4 PRODUCT PORTFOLIO
16.11.5 RECENT DEVELOPMENTS
16.12 ADVANCED ARTIFICIAL EYE
16.12.1 COMPANY OVERVIEW
16.12.2 REVENUE ANALYSIS
16.12.3 GEOGRAPHIC PRESENCE
16.12.4 PRODUCT PORTFOLIO
16.12.5 RECENT DEVELOPMENTS
16.13 NATIONAL ARTIFICIAL EYE SERVICES (NHS)
16.13.1 COMPANY OVERVIEW
16.13.2 REVENUE ANALYSIS
16.13.3 GEOGRAPHIC PRESENCE
16.13.4 PRODUCT PORTFOLIO
16.13.5 RECENT DEVELOPMENTS
16.14 MED-EL
16.14.1 COMPANY OVERVIEW
16.14.2 REVENUE ANALYSIS
16.14.3 GEOGRAPHIC PRESENCE
16.14.4 PRODUCT PORTFOLIO
16.14.5 RECENT DEVELOPMENTS
16.15 SANTEN PHARMACEUTICAL
16.15.1 COMPANY OVERVIEW
16.15.2 REVENUE ANALYSIS
16.15.3 GEOGRAPHIC PRESENCE
16.15.4 PRODUCT PORTFOLIO
16.15.5 RECENT DEVELOPMENTS
16.16 NIDEK CO., LTD.
16.16.1 COMPANY OVERVIEW
16.16.2 REVENUE ANALYSIS
16.16.3 GEOGRAPHIC PRESENCE
16.16.4 PRODUCT PORTFOLIO
16.16.5 RECENT DEVELOPMENTS
16.17 HOYA CORPORATION
16.17.1 COMPANY OVERVIEW
16.17.2 REVENUE ANALYSIS
16.17.3 GEOGRAPHIC PRESENCE
16.17.4 PRODUCT PORTFOLIO
16.17.5 RECENT DEVELOPMENTS
16.18 OCULENTIS GMBH
16.18.1 COMPANY OVERVIEW
16.18.2 REVENUE ANALYSIS
16.18.3 GEOGRAPHIC PRESENCE
16.18.4 PRODUCT PORTFOLIO
16.18.5 RECENT DEVELOPMENTS
16.19 RAYNER INTRAOCULAR LENSES LIMITED
16.19.1 COMPANY OVERVIEW
16.19.2 REVENUE ANALYSIS
16.19.3 GEOGRAPHIC PRESENCE
16.19.4 PRODUCT PORTFOLIO
16.19.5 RECENT DEVELOPMENTS
16.2 HUMANOPTICS AG
16.20.1 COMPANY OVERVIEW
16.20.2 REVENUE ANALYSIS
16.20.3 GEOGRAPHIC PRESENCE
16.20.4 PRODUCT PORTFOLIO
16.20.5 RECENT DEVELOPMENTS
16.21 PHYSIOL
16.21.1 COMPANY OVERVIEW
16.21.2 REVENUE ANALYSIS
16.21.3 GEOGRAPHIC PRESENCE
16.21.4 PRODUCT PORTFOLIO
16.21.5 RECENT DEVELOPMENTS
16.22 VSY BIOTECHNOLOGY
16.22.1 COMPANY OVERVIEW
16.22.2 REVENUE ANALYSIS
16.22.3 GEOGRAPHIC PRESENCE
16.22.4 PRODUCT PORTFOLIO
16.22.5 RECENT DEVELOPMENTS
16.23 LENSTEC, INC.
16.23.1 COMPANY OVERVIEW
16.23.2 REVENUE ANALYSIS
16.23.3 GEOGRAPHIC PRESENCE
16.23.4 PRODUCT PORTFOLIO
16.23.5 RECENT DEVELOPMENTS
16.24 BIOTECH HEALTHCARE GROUP
16.24.1 COMPANY OVERVIEW
16.24.2 REVENUE ANALYSIS
16.24.3 GEOGRAPHIC PRESENCE
16.24.4 PRODUCT PORTFOLIO
16.24.5 RECENT DEVELOPMENTS
16.25 EYEKON MEDICAL, INC.
16.25.1 COMPANY OVERVIEW
16.25.2 REVENUE ANALYSIS
16.25.3 GEOGRAPHIC PRESENCE
16.25.4 PRODUCT PORTFOLIO
16.25.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
17 RELATED REPORTS
18 QUESTIONNAIRE
19 ABOUT DATA BRIDGE MARKET RESEARCH
